References
- Abildgaard U. Acceleration of fibrin polymeri zation by dextran and ficoll. Interaction with calcium and plasma proteins. Scand. J. clin. Lab. Invest. 1966; 18: 518
- Bachman F., Duckert F., Koller F. The Stuart-Prower factor assay and its clinical signification. Thrombos. Diathes. haemorrh. (Stuttg.) 1958; 2: 24
- Bergna L. J. A simple method for the assay of factor VIII. Blood 1960; 15: 637
- Biggs R., Douglas A. S., Macfarlane R. G. The action of thromboplastic substances. J. Physiol. (Land.) 1953; 122: 554
- Blombäck B. Swedish Patent, nr. 8861/68
- Blombäck M. Purification of antihemophilic globulin. Arkiv Kemi 1958; 12: 387
- Blombäck B., Blombäck M. Purification of human and bovine fibrinogen. Arkiv Kemi 1956; 10: 415
- Blombäck B., Blombäck M. A method for the assay of factor V. Scand. J. clin. Lab. In vest. 1963; 15: 639
- Blombäck B., Blombäck M., Olsson P. Studies on thrombin inactivation in normal plasma, serum and plasma fractions and its relation to heparin. Thrombos. Diathes. haem orrh. (Stung.) 1953; 9: 368
- Blombäck B., Yamashina I. On the N-terminal amino-acids in fibrinogen and fibrin. Arkiv Kemi 1958; 12: 299
- Brinkhous K. M., Smith H. P., Warner E. D., Seegers W. H. The inhibition of blood clotting: an unidentified substance which acts in conjunction with heparin to prevent the conversion of prothrombin into thrombin. Amer. J. Physiol. 1939; 125: 683
- Cohn E. J., Strong L. E., Hughes W. L., Jr., Mulford D. J., Ashworth I. N., Melin M., Taylor H. L. Preparation and properties of serum and plasma proteins. IV. A system for the separation into fractions of the protein and lipoprotein components of biological tis sues and fluids. J. Amer. chem. Soc. 1946; 68: 459
- Ganrot P. O., Nihlén J.-E. Immunochemical determination of prothrombin. Scand. J. clin. Lab. Invest. 1968; 21: 238
- Goldstein R., Bolloc'h A. L., Alexander B., Zonderman E. Preparation and properties of prothrombin. J. biol. Chem. 1959; 234: 2857
- Gonyea L. M., Bridges R. A. Electro phoretic behaviour of bovine prothrombin. Scand. J. clin. Lab. Invest. 1965; 17, Suppl. 84
- Hjort P., Rapport I., Owren P. A simple, specific one-stage pothrombin assay using Russell's viper venom in cephalin suspension. J. Lab. clin. Med. 1955; 46: 89
- Horowitz H. I., Wilcox W. P., Fujimoto M. M. Assay of plasma thromboplastin ante cedent (PTA) with artificially depleted normal plasma. Blood 1963; 22: 35
- Josso F., Lavergue J. M., Weilland C., Soulier J. P. Étuds immunologique de la pro thrombine et de la thrombine humaines. Thrombos. Diathes. haermorrh. (Stuttg.) 1967; 18: 311
- Koller F., Loeliger A., Duckert F. Experi ments on a new clotting factor (factor VII). Acta haemat. 1951; 6: 1
- Laurell A. B. Influence of dextran on the conversion of fibrinogen to fibrin. Scand. J. clin. Lab. Invest. 1951; 3: 262
- Moore H. C., Lux S. E., Malhotra O. P., Bakerman S., Carter J. R. Isolation and purification of bovine and canine prothrombin. Biochim. biophys. Acta (Amst.) 1965; 111: 174
- Nilsson I.-M., Blombäck M., Francken I. von. On an inherited autosomal hemorrhagic diathesis with antihemophilic globulin (AHG) deficiency and prolonged bleeding time. Acta med. scand. 1957; 159: 35
- Nilsson I.-M., Blombäck M., Ramgren O. Hemophilia in Sweden. I. Coagulation studies. Acta med. scand. 1961; 170: 665
- Norén I., Blombäck M. New rapid test for coagulation disorders. Xth Congr. Intern. Soc. Haematol. 1964
- Owren P. A., Aas R. The control of di cumarol therapy and the quantitative deter mination of prothrombin and proconvertin. Scand. J. clin. Lab. Invest. 1951; 3: 201
- Porter P., Porter M., Shanberge J. N. Heparin co-factor and plasma antithrombin in relation to the mechanism of inactivation of thrombin by heparin. Clin. chim. Acta 1967; 17: 189
- Quick A. J., Stanley-Brown M., Bancroft F. W. A study of the coagulation defect in hemophilia and in jaundice. Amer. J. med. Sci. 1935; 190: 501
- Stormorken H., Hjort P. Assay of pro thrombin. Proc. 6th Congr. Europ. Soc. Haematol. 1957
- Wallén P. Personal communication
- Ware A. G., Seegers W. H. Two stage procedure for the quantitative determination of prothrombin concentration. Amer. J. clin. Path. 1949; 19: 471
- Warner E. D., Brinkhous R. M., Smith H. P. A quantitative study on blood clotting: prothrombin fluctuations under experimental conditions. Amer. J. Physiol. 1936; 114: 667
- Wolf P. A modification for routine labora tory use of Stefanini's method of estimating factor V activity in human oxalated plasma. J. clin. Path. 1953; 6: 34